Healthcare

Global Neuromodulation Devices Market, Forecast to 2027

Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements

INDUSTRY
Healthcare

RELEASE DATE
19-Sep-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K94B-01-00-00-00
SKU
HC_2023_153
Yes
SHARE

Global Neuromodulation Devices Market, Forecast to 2027
Published on: 19-Sep-2023 | SKU: HC_2023_153

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This Frost & Sullivan research service analyzes the neuromodulation market, including the market landscape of major neuromodulation technologies and regions, and the market share of key participants. It also examines new applications, technologies, and trends in the industry. The study provides market estimates and forecasts from 2021 to 2027 and highlights new opportunities in neuromodulation devices, innovations, and unaddressed markets.

The neuromodulation devices market is highly competitive as new innovative technologies are constantly introduced and many new start-ups are entering through new application areas and disease indications. Furthermore, advances in sensing, neuroimaging, artificial intelligence, virtual care, and telemedicine are positively impacting market growth.

Major applications for neuromodulation technologies include deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation, and cochlear implants, which are covered in this study, as are various neuromodulation techniques and devices are used for different disease areas—movement disorders, neurological diseases, and chronic pain, among others.

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Neuromodulation Devices Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Key Competitors

Key Competitors (continued)

Growth Metrics

Growth Drivers

Growth Restraints

Device Challenges

New Product Approvals

Investment Scenario

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Product

Revenue Forecast by Region

Revenue Forecast Analysis

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share (continued)

Revenue Share Analysis

Applications

Applications (Continued)

Key Indications and Prevalence

Key Indications and Prevalence (continued)

End User

Digital Health Integration in Neuromodulation

Digital Health Integration in Neuromodulation (continued)

Personalization

New Technologies

Non-invasive Technologies

Future Trends

Growth Metrics

Revenue Forecast

Revenue Forecast by Product

Forecast Analysis by Product

Growth Metrics

Revenue Forecast

Revenue Forecast by Product

Forecast Analysis by Product

Growth Metrics

Revenue Forecast

Revenue Forecast by Product

Forecast Analysis by Product

Growth Metrics

Revenue Forecast

Revenue Forecast by Product

Forecast Analysis by Product

Growth Metrics

Revenue Forecast

Revenue Forecast by Product

Forecast Analysis by Product

Growth Opportunity 1: Expanding Clinical Indications

Growth Opportunity 1: Expanding Clinical Indications (continued)

Growth Opportunity 2: Digitalization

Growth Opportunity 2: Digitalization (continued)

Growth Opportunity 3: Non-invasive/Minimally Invasive Solutions

Growth Opportunity 3: Non-invasive/Minimally Invasive Solutions (continued)

Growth Opportunity 4: Neuromodulation Personalization

Growth Opportunity 4: Neuromodulation Personalization (continued)

Growth Opportunity 5: Emerging Markets

Growth Opportunity 5: Emerging Markets (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • Neuromodulation Devices: Growth Metrics, Global, 2022
  • Neuromodulation Devices: Growth Drivers, Global, 2023–2027
  • Neuromodulation Devices: Growth Restraints, Global, 2023–2027
  • Neuromodulation Devices: Challenges, Global, 2022
  • Neuromodulation Devices: US FDA-approved Devices, Global, 2021–June 2023
  • Neuromodulation Devices: Recent Investments, Global
  • Neuromodulation Devices: Revenue Forecast, Global, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Product, Global, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Region, Global, 2020–2027
  • Neuromodulation Devices: Revenue Share of Top Participants, Global, 2022
  • Neuromodulation Devices: Application Areas for Neuromodulation, Global, 2022
  • Neuromodulation Devices: Key Indications and Prevalence, Global, 2022
  • Neuromodulation Devices: Non-invasive Technologies, Global, 2022
  • Neuromodulation Devices: Growth Metrics, North America, 2022
  • Neuromodulation Devices: Revenue Forecast, North America, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Product, North America, 2020–2027
  • Neuromodulation Devices: Growth Metrics, Europe, 2022
  • Neuromodulation Devices: Revenue Forecast, Europe, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Product, Europe, 2020–2027
  • Neuromodulation Devices: Growth Metrics, Asia-Pacific, 2022
  • Neuromodulation Devices: Revenue Forecast, Asia-Pacific, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Product, Asia-Pacific, 2020–2027
  • Neuromodulation Devices: Growth Metrics, MENASA, 2022
  • Neuromodulation Devices: Revenue Forecast, MENASA, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Product, MENASA, 2020–2027
  • Neuromodulation Devices: Growth Metrics, Latin America and the Caribbean, 2022
  • Neuromodulation Devices: Revenue Forecast, Latin America and the Caribbean, 2020–2027
  • Neuromodulation Devices: Revenue Forecast by Product, Latin America and the Caribbean, 2020–2027

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.